Sign in
Taking people in United StatesNo phase

Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study

Key facts

Who runs it
KidSIM Simulation Program
Where
Los Angeles, United StatesSee the siteAlso in 1 other country, 3 sites
Trial code
Status
Recruiting
People taking part
240 people, planned
Started
1 Sept 2023
Expected to end
1 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Aerosol box
Record updated
5 September 2025

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Airway Provider:
  • Attending physician, fellow or resident in adult or pediatric emergency medicine, pediatric intensive care, general pediatrics or pediatric/adult anesthesia
  • Adult or Pediatric Advanced Life Support certification; CPR Provider:
  • Attending physician, resident, fellow, nurse, respiratory therapist, physician assistant or health care aide
  • Basic Life Support, Adult or Pediatric Advanced Life Support certification

Who cannot take part

  • Decline to provide informed consent
  • Unable to perform tasks required of the role due to physical limitations

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Where in United States

Also in 1 other country, 3 sites

  • Department of Emergency Medicine, Children's Hospital of Los AngelesLos Angeles, United StatesContact: Todd Chang, MDTaking people

About the trial

What the trial wants to find out

Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients infected with SARS-CoV-2 experience unusually high rates of critical illness that needs advanced airway management and intensive care unit admission. Bag-valve-mask (BVM) ventilation, endotracheal Intubation (ETI) and chest compressions are sometimes required for critically ill COVID-19 patients, and may contribute to a high risk of infection amongst Health Care Workers (HCW). To lessen HCW risk during high-risk procedures, a device called an aerosol box has been developed to place over the head of the patient, shielding the provider's face from virus droplets suspended in the air.

Read full original descriptionShow less

The purpose of this research study is to better understand how particles disperse during AGMPs, more specifically during the provision of cardiopulmonary resuscitation (CPR). The project team hopes what is learned from the project can help inform infection control measures. This could help make changes to the clinical environment and make it safer for HCW's. The investigators intend to explore how an aerosol box performs in reducing contamination of HCW's who perform critical airway interventions during resuscitation events.

The 2 groups in the trial

  • Aerosol BoxTreatment being tested

    The team will complete the resuscitation scenario with an Aerosol box placed.

  • No Aerosol BoxNo study treatment, for comparison

    The team will complete the resuscitation scenario without an Aerosol box placed.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT05868239, who can take part
Record updated
5 September 2025